Promethium Advisors
PFE icon

Promethium Advisors’s Pfizer PFE Stock Holding History

Promethium Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.32M Hold
81,378
– – 1.14% 27
2026
Q2 		$1.96M Hold
81,378
– – 0.94% 32
2026
Q1 		$2.29M Hold
81,378
– – 1.18% 26
2025
Q4 		$2.03M Sell
81,378
-21,642
-21% -$546K 1.09% 30
2025
Q3 		$2.62M Hold
103,020
– – 1.51% 20
2025
Q2 		$2.5M Sell
103,020
-75
-0.1% -$1.75K 1.52% 22
2025
Q1 		$2.61M Sell
103,095
-29,162
-22% -$763K 1.67% 18
2024
Q4 		$3.51M Sell
132,257
-1,380
-1% -$37.4K 2.4% 7
2024
Q3 		$3.87M Buy
+133,637
New +$3.9M 2.73% 3

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Promethium Advisors's PFE Position: Q3 2026 in Review

Promethium Advisors held its Pfizer (PFE) position steady in Q3 2026 at 81,378 shares worth $2.32M. The position accounts for 1.14% of the portfolio, ranked #27.

Promethium Advisors first reported a position in PFE in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.87M in Q3 2024. 1,861 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Promethium Advisors held 81,378 shares of Pfizer worth $2.32M as of Q3 2026.
  • Promethium Advisors left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 1.14% of Promethium Advisors's portfolio in Q3 2026, its #27 holding.
  • Promethium Advisors first reported a position in Pfizer in Q3 2024 and has held it in 9 quarters since.
  • Promethium Advisors's Pfizer position peaked at $3.87M in Q3 2024.
  • 1,861 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Promethium Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.